"alt_sample_name"	"unique_patient_ID"	"sample_type"	"histological_type"	"primarysite"	"arrayedsite"	"summarygrade"	"summarystage"	"tumorstage"	"substage"	"grade"	"age_at_initial_pathologic_diagnosis"	"pltx"	"tax"	"neo"	"days_to_tumor_recurrence"	"recurrence_status"	"days_to_death"	"vital_status"	"os_binary"	"relapse_binary"	"site_of_tumor_first_recurrence"	"primary_therapy_outcome_success"	"debulking"	"percent_normal_cells"	"percent_stromal_cells"	"percent_tumor_cells"	"batch"	"flag"	"flag_notes"	"uncurated_author_metadata"
"GSM1078972"	"Tc_113"	NA	"tumor"	"clearcell"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-14"	NA	NA	"title: Tc_113///geo_accession: GSM1078972///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c113///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078972/GSM1078972_c113.CEL.gz///data_row_count: 54675"
"GSM1078973"	"Tc_48"	NA	"tumor"	"clearcell"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Tc_48///geo_accession: GSM1078973///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c48///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078973/GSM1078973_c48.CEL.gz///data_row_count: 54675"
"GSM1078974"	"Tc_49"	NA	"tumor"	"clearcell"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Tc_49///geo_accession: GSM1078974///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c49///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078974/GSM1078974_c49.CEL.gz///data_row_count: 54675"
"GSM1078975"	"Tc_51"	NA	"tumor"	"clearcell"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Tc_51///geo_accession: GSM1078975///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c51///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078975/GSM1078975_c51.CEL.gz///data_row_count: 54675"
"GSM1078976"	"Tc_56"	NA	"tumor"	"clearcell"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Tc_56///geo_accession: GSM1078976///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c56///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078976/GSM1078976_c56.CEL.gz///data_row_count: 54675"
"GSM1078977"	"Tc_59"	NA	"tumor"	"clearcell"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Tc_59///geo_accession: GSM1078977///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c59///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078977/GSM1078977_c59.CEL.gz///data_row_count: 54675"
"GSM1078978"	"Tc_61"	NA	"tumor"	"clearcell"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Tc_61///geo_accession: GSM1078978///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c61///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078978/GSM1078978_c61.CEL.gz///data_row_count: 54675"
"GSM1078979"	"Tc_63"	NA	"tumor"	"clearcell"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Tc_63///geo_accession: GSM1078979///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c63///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078979/GSM1078979_c63.CEL.gz///data_row_count: 54675"
"GSM1078980"	"Tc_64"	NA	"tumor"	"clearcell"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Tc_64///geo_accession: GSM1078980///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c64///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078980/GSM1078980_c64.CEL.gz///data_row_count: 54675"
"GSM1078981"	"Tc_65"	NA	"tumor"	"clearcell"	NA	NA	NA	"early"	2	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"long"	"short"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Tc_65///geo_accession: GSM1078981///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage II///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c65///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078981/GSM1078981_c65.CEL.gz///data_row_count: 54675"
"GSM1078982"	"Tc_74"	NA	"tumor"	"clearcell"	NA	NA	NA	"late"	4	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"long"	"short"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Tc_74///geo_accession: GSM1078982///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage IV///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c74///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078982/GSM1078982_c74.CEL.gz///data_row_count: 54675"
"GSM1078983"	"Tc_94"	NA	"tumor"	"clearcell"	NA	NA	NA	"late"	4	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"short"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Tc_94///geo_accession: GSM1078983///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: clear cell///characteristics_ch1.2: advanced disease stage: stage IV///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: c94///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078983/GSM1078983_c94.CEL.gz///data_row_count: 54675"
"GSM1078984"	"Te_69"	NA	"tumor"	"endo"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"short"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Te_69///geo_accession: GSM1078984///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e69///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078984/GSM1078984_e69.CEL.gz///data_row_count: 54675"
"GSM1078985"	"Te_77"	NA	"tumor"	"endo"	NA	NA	NA	"early"	2	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"short"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Te_77///geo_accession: GSM1078985///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage II///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e77///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078985/GSM1078985_e77.CEL.gz///data_row_count: 54675"
"GSM1078986"	"Te_78"	NA	"tumor"	"endo"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Te_78///geo_accession: GSM1078986///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e78///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078986/GSM1078986_e78.CEL.gz///data_row_count: 54675"
"GSM1078987"	"Te_79"	NA	"tumor"	"endo"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Te_79///geo_accession: GSM1078987///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e79///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078987/GSM1078987_e79.CEL.gz///data_row_count: 54675"
"GSM1078988"	"Te_84"	NA	"tumor"	"endo"	NA	NA	NA	"early"	2	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Te_84///geo_accession: GSM1078988///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage II///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e84///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078988/GSM1078988_e84.CEL.gz///data_row_count: 54675"
"GSM1078989"	"Te_87"	NA	"tumor"	"endo"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Te_87///geo_accession: GSM1078989///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e87///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078989/GSM1078989_e87.CEL.gz///data_row_count: 54675"
"GSM1078990"	"Te_89"	NA	"tumor"	"endo"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Te_89///geo_accession: GSM1078990///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e89///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078990/GSM1078990_e89.CEL.gz///data_row_count: 54675"
"GSM1078991"	"Te_90"	NA	"tumor"	"endo"	NA	NA	NA	"late"	4	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Te_90///geo_accession: GSM1078991///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage IV///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e90///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078991/GSM1078991_e90.CEL.gz///data_row_count: 54675"
"GSM1078992"	"Te_91"	NA	"tumor"	"endo"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Te_91///geo_accession: GSM1078992///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e91///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078992/GSM1078992_e91.CEL.gz///data_row_count: 54675"
"GSM1078993"	"Te_92"	NA	"tumor"	"endo"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Te_92///geo_accession: GSM1078993///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e92///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078993/GSM1078993_e92.CEL.gz///data_row_count: 54675"
"GSM1078994"	"Te_93"	NA	"tumor"	"endo"	NA	NA	NA	"early"	2	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Te_93///geo_accession: GSM1078994///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: endometrioid///characteristics_ch1.2: advanced disease stage: stage II///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: e93///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078994/GSM1078994_e93.CEL.gz///data_row_count: 54675"
"GSM1078995"	"Tm_101"	NA	"tumor"	"mucinous"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"short"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Tm_101///geo_accession: GSM1078995///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: mucinous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: m101///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078995/GSM1078995_m101.CEL.gz///data_row_count: 54675"
"GSM1078996"	"Tm_102"	NA	"tumor"	"mucinous"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Tm_102///geo_accession: GSM1078996///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: mucinous///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: m102///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078996/GSM1078996_m102.CEL.gz///data_row_count: 54675"
"GSM1078997"	"Tm_106"	NA	"tumor"	"mucinous"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-14"	NA	NA	"title: Tm_106///geo_accession: GSM1078997///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: mucinous///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: m106///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078997/GSM1078997_m106.CEL.gz///data_row_count: 54675"
"GSM1078998"	"Tm_107"	NA	"tumor"	"mucinous"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-14"	NA	NA	"title: Tm_107///geo_accession: GSM1078998///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: mucinous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: m107///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078998/GSM1078998_m107.CEL.gz///data_row_count: 54675"
"GSM1078999"	"Tm_110"	NA	"tumor"	"mucinous"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-14"	NA	NA	"title: Tm_110///geo_accession: GSM1078999///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: mucinous///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: m110///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1078nnn/GSM1078999/GSM1078999_m110.CEL.gz///data_row_count: 54675"
"GSM1079000"	"Tm_95"	NA	"tumor"	"mucinous"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Tm_95///geo_accession: GSM1079000///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: mucinous///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: m95///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079000/GSM1079000_m95.CEL.gz///data_row_count: 54675"
"GSM1079001"	"Tm_96"	NA	"tumor"	"mucinous"	NA	NA	NA	"early"	2	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Tm_96///geo_accession: GSM1079001///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: mucinous///characteristics_ch1.2: advanced disease stage: stage II///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: m96///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079001/GSM1079001_m96.CEL.gz///data_row_count: 54675"
"GSM1079002"	"Tm_97"	NA	"tumor"	"mucinous"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Tm_97///geo_accession: GSM1079002///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: mucinous///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: m97///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079002/GSM1079002_m97.CEL.gz///data_row_count: 54675"
"GSM1079003"	"Tm_98"	NA	"tumor"	"mucinous"	NA	NA	NA	"early"	2	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Tm_98///geo_accession: GSM1079003///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: mucinous///characteristics_ch1.2: advanced disease stage: stage II///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: m98///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079003/GSM1079003_m98.CEL.gz///data_row_count: 54675"
"GSM1079004"	"Ts_11"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"long"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_11///geo_accession: GSM1079004///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s11///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079004/GSM1079004_s11.CEL.gz///data_row_count: 54675"
"GSM1079005"	"Ts_14"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_14///geo_accession: GSM1079005///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s14///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079005/GSM1079005_s14.CEL.gz///data_row_count: 54675"
"GSM1079006"	"Ts_15"	NA	"tumor"	"ser"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-12-10"	NA	NA	"title: Ts_15///geo_accession: GSM1079006///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s15///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079006/GSM1079006_s15.CEL.gz///data_row_count: 54675"
"GSM1079007"	"Ts_17"	NA	"tumor"	"ser"	NA	NA	NA	"early"	1	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Ts_17///geo_accession: GSM1079007///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage I///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s17///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079007/GSM1079007_s17.CEL.gz///data_row_count: 54675"
"GSM1079008"	"Ts_19"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_19///geo_accession: GSM1079008///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s19///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079008/GSM1079008_s19.CEL.gz///data_row_count: 54675"
"GSM1079009"	"Ts_20"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"short"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Ts_20///geo_accession: GSM1079009///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s20///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079009/GSM1079009_s20.CEL.gz///data_row_count: 54675"
"GSM1079010"	"Ts_21"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"long"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_21///geo_accession: GSM1079010///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s21///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079010/GSM1079010_s21.CEL.gz///data_row_count: 54675"
"GSM1079011"	"Ts_23"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Ts_23///geo_accession: GSM1079011///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s23///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079011/GSM1079011_s23.CEL.gz///data_row_count: 54675"
"GSM1079012"	"Ts_24"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"long"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_24///geo_accession: GSM1079012///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s24///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079012/GSM1079012_s24.CEL.gz///data_row_count: 54675"
"GSM1079013"	"Ts_26"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-08"	NA	NA	"title: Ts_26///geo_accession: GSM1079013///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s26///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079013/GSM1079013_s26.CEL.gz///data_row_count: 54675"
"GSM1079014"	"Ts_28"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_28///geo_accession: GSM1079014///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s28///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079014/GSM1079014_s28.CEL.gz///data_row_count: 54675"
"GSM1079015"	"Ts_2"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_2///geo_accession: GSM1079015///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s2///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079015/GSM1079015_s2.CEL.gz///data_row_count: 54675"
"GSM1079016"	"Ts_31"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_31///geo_accession: GSM1079016///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s31///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079016/GSM1079016_s31.CEL.gz///data_row_count: 54675"
"GSM1079017"	"Ts_32"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Ts_32///geo_accession: GSM1079017///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s32///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079017/GSM1079017_s32.CEL.gz///data_row_count: 54675"
"GSM1079018"	"Ts_34"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_34///geo_accession: GSM1079018///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s34///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079018/GSM1079018_s34.CEL.gz///data_row_count: 54675"
"GSM1079019"	"Ts_35"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Ts_35///geo_accession: GSM1079019///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s35///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079019/GSM1079019_s35.CEL.gz///data_row_count: 54675"
"GSM1079020"	"Ts_36"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"long"	"short"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Ts_36///geo_accession: GSM1079020///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s36///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079020/GSM1079020_s36.CEL.gz///data_row_count: 54675"
"GSM1079021"	"Ts_37"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Ts_37///geo_accession: GSM1079021///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s37///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079021/GSM1079021_s37.CEL.gz///data_row_count: 54675"
"GSM1079022"	"Ts_39"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"long"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_39///geo_accession: GSM1079022///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s39///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079022/GSM1079022_s39.CEL.gz///data_row_count: 54675"
"GSM1079023"	"Ts_3"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"long"	"short"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Ts_3///geo_accession: GSM1079023///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s3///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079023/GSM1079023_s3.CEL.gz///data_row_count: 54675"
"GSM1079024"	"Ts_41"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_41///geo_accession: GSM1079024///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s41///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079024/GSM1079024_s41.CEL.gz///data_row_count: 54675"
"GSM1079025"	"Ts_43"	NA	"tumor"	"ser"	NA	NA	NA	"early"	2	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_43///geo_accession: GSM1079025///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage II///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s43///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079025/GSM1079025_s43.CEL.gz///data_row_count: 54675"
"GSM1079026"	"Ts_45"	NA	"tumor"	"ser"	NA	NA	NA	"late"	4	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_45///geo_accession: GSM1079026///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage IV///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s45///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079026/GSM1079026_s45.CEL.gz///data_row_count: 54675"
"GSM1079027"	"Ts_46"	NA	"tumor"	"ser"	NA	NA	NA	"early"	2	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_46///geo_accession: GSM1079027///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage II///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s46///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079027/GSM1079027_s46.CEL.gz///data_row_count: 54675"
"GSM1079028"	"Ts_47"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"norecurrence"	NA	NA	"long"	"long"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_47///geo_accession: GSM1079028///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: non-recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s47///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079028/GSM1079028_s47.CEL.gz///data_row_count: 54675"
"GSM1079029"	"Ts_4"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-10-14"	NA	NA	"title: Ts_4///geo_accession: GSM1079029///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s4///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079029/GSM1079029_s4.CEL.gz///data_row_count: 54675"
"GSM1079030"	"Ts_5"	NA	"tumor"	"ser"	NA	NA	NA	"late"	4	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"short"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-07"	NA	NA	"title: Ts_5///geo_accession: GSM1079030///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage IV///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: death///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s5///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079030/GSM1079030_s5.CEL.gz///data_row_count: 54675"
"GSM1079031"	"Ts_8"	NA	"tumor"	"ser"	NA	NA	NA	"late"	3	NA	NA	NA	NA	NA	NA	NA	"recurrence"	NA	NA	"long"	"short"	NA	NA	NA	NA	NA	NA	"2010-09-08"	NA	NA	"title: Ts_8///geo_accession: GSM1079031///status: Public on Jan 01 2014///submission_date: Feb 06 2013///last_update_date: Jan 01 2014///type: RNA///channel_count: 1///source_name_ch1: primary surgical treatment///organism_ch1: Homo sapiens///characteristics_ch1: tissue: ovarian cancer cells///characteristics_ch1.1: tissue subtype: serous///characteristics_ch1.2: advanced disease stage: stage III///characteristics_ch1.3: recurrence status: recurrence///characteristics_ch1.4: survival/death: survival///treatment_protocol_ch1: Frozen rissues///growth_protocol_ch1: Frozen tissue samples were embedded, and sections were cut and mounted on slides. The slides were stained with H&E to ensure that at least 70% of the cellular content was comprised of epithelial ovarian cancer cells.///molecule_ch1: total RNA///extract_protocol_ch1: Trizol extraction of total RNA was performed according to the manufacturer's instructions.///label_ch1: biotin///label_protocol_ch1: biotin///taxid_ch1: 9606///hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450///scan_protocol: The arrays were scanned to a target intensity of 500 by a GeneArray Scanner, and patterns of hybridization were detected as light emitted from the fluorescent reporter groups incorporated into the target and hybridized to oligonucleotide probes.///description: s8///data_processing: The CEL files were generated using Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings. Signal intensities were derived from CEL files and Signal intensity derived from the CEL files, using GCRMA method.///platform_id: GPL570///contact_name: Tzu-Hao,,Chang///contact_department: Graduate Institute of Biomedical Informatics///contact_institute: Taipei Medical University///contact_address: 250 Wu-Xin Street///contact_city: Taipei///contact_zip.postal_code: 110///contact_country: Taiwan///supplementary_file: ftp://ftp.ncbi.nlm.nih.gov/pub/geo/DATA/supplementary/samples/GSM1079nnn/GSM1079031/GSM1079031_s8.CEL.gz///data_row_count: 54675"
